(Q36498667)

English

Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

dermatomyositis

0 references

author name string

N Martin

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

P Krol

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

S Smith

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

L Beard

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

C A Pilkington

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

J Davidson

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

L R Wedderburn

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Juvenile Dermatomyositis Research Group (JDRG)

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

1 November 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

64

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1665-1672

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Juvenile dermatomyositis: extramuscular manifestations and their management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Development and validation of the Dermatomyositis Skin Severity Index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

30 September 2017

US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533762

21 September 2018

Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21753

21 January 2018

Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyos

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The incidence of juvenile dermatomyositis: results from a nation-wide study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22674907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ACR.21753

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36498667&oldid=1635630869"